LCM
IRMD icon

Legato Capital Management’s iRadimed IRMD Stock Holding History

Legato Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$637K Sell
6,613
-2,064
-24% -$206K 0.06% 465
2025
Q4 		$844K Sell
8,677
-4,123
-32% -$354K 0.07% 398
2025
Q3 		$911K Hold
12,800
– – 0.1% 312
2025
Q2 		$765K Hold
12,800
– – 0.09% 347
2025
Q1 		$672K Sell
12,800
-176
-1% -$9.89K 0.09% 357
2024
Q4 		$714K Hold
12,976
– – 0.09% 378
2024
Q3 		$653K Hold
12,976
– – 0.08% 393
2024
Q2 		$570K Buy
12,976
+1,727
+15% +$73.4K 0.08% 409
2024
Q1 		$495K Buy
11,249
+1,944
+21% +$85.9K 0.06% 443
2023
Q4 		$442K Hold
9,305
– – 0.06% 438
2023
Q3 		$413K Buy
9,305
+4,365
+88% +$203K 0.06% 436
2023
Q2 		$236K Buy
+4,940
New +$223K 0.03% 506

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Legato Capital Management's IRMD Position: Q1 2026 in Review

Legato Capital Management reduced its iRadimed (IRMD) stake by 24% in Q1 2026, selling an estimated $206K and leaving 6,613 shares worth $637K. The position accounts for 0.06% of the portfolio, ranked #465.

Legato Capital Management first reported a position in IRMD in Q2 2023 and has held it in 12 quarters since. The position peaked at $911K in Q3 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Legato Capital Management held 6,613 shares of iRadimed worth $637K as of Q1 2026.
  • Legato Capital Management sold 2,064 iRadimed shares in Q1 2026, an estimated $206K.
  • iRadimed made up 0.06% of Legato Capital Management's portfolio in Q1 2026, its #465 holding.
  • Legato Capital Management first reported a position in iRadimed in Q2 2023 and has held it in 12 quarters since.
  • Legato Capital Management's iRadimed position peaked at $911K in Q3 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.